Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters











Language
Publication year range
2.
Clinics (Sao Paulo) ; 70(5): 326-32, 2015 May.
Article in English | MEDLINE | ID: mdl-26039948

ABSTRACT

OBJECTIVE: Studies suggest an association between vitamin D deficiency and morbidity/mortality in critically ill patients. Several issues remain unexplained, including which vitamin D levels are related to morbidity and mortality and the relevance of vitamin D kinetics to clinical outcomes. We conducted this study to address the association of baseline vitamin D levels and vitamin D kinetics with morbidity and mortality in critically ill patients. METHOD: In 135 intensive care unit (ICU) patients, vitamin D was prospectively measured on admission and weekly until discharge from the ICU. The following outcomes of interest were analyzed: 28-day mortality, mechanical ventilation, length of stay, infection rate, and culture positivity. RESULTS: Mortality rates were higher among patients with vitamin D levels <12 ng/mL (versus vitamin D levels >12 ng/mL) (32.2% vs. 13.2%), with an adjusted relative risk of 2.2 (95% CI 1.07-4.54; p< 0.05). There were no differences in the length of stay, ventilation requirements, infection rate, or culture positivity. CONCLUSIONS: This study suggests that low vitamin D levels on ICU admission are an independent risk factor for mortality in critically ill patients. Low vitamin D levels at ICU admission may have a causal relationship with mortality and may serve as an indicator for vitamin D replacement among critically ill patients.


Subject(s)
Vitamin D Deficiency/blood , Vitamin D Deficiency/mortality , Vitamin D/blood , APACHE , Adult , Aged , Brazil/epidemiology , Critical Illness , Dialysis , Female , Hospital Mortality , Humans , Intensive Care Units/statistics & numerical data , Length of Stay , Male , Middle Aged , Organ Dysfunction Scores , Parathyroid Hormone/blood , Patient Admission , Patient Discharge , Prospective Studies , Respiration, Artificial , Risk , Sensitivity and Specificity
3.
Clinics ; Clinics;70(5): 326-332, 05/2015. tab, graf
Article in English | LILACS | ID: lil-748274

ABSTRACT

OBJECTIVE: Studies suggest an association between vitamin D deficiency and morbidity/mortality in critically ill patients. Several issues remain unexplained, including which vitamin D levels are related to morbidity and mortality and the relevance of vitamin D kinetics to clinical outcomes. We conducted this study to address the association of baseline vitamin D levels and vitamin D kinetics with morbidity and mortality in critically ill patients. METHOD: In 135 intensive care unit (ICU) patients, vitamin D was prospectively measured on admission and weekly until discharge from the ICU. The following outcomes of interest were analyzed: 28-day mortality, mechanical ventilation, length of stay, infection rate, and culture positivity. RESULTS: Mortality rates were higher among patients with vitamin D levels <12 ng/mL (versus vitamin D levels >12 ng/mL) (32.2% vs. 13.2%), with an adjusted relative risk of 2.2 (95% CI 1.07-4.54; p< 0.05). There were no differences in the length of stay, ventilation requirements, infection rate, or culture positivity. CONCLUSIONS: This study suggests that low vitamin D levels on ICU admission are an independent risk factor for mortality in critically ill patients. Low vitamin D levels at ICU admission may have a causal relationship with mortality and may serve as an indicator for vitamin D replacement among critically ill patients. .


Subject(s)
Adult , Humans , Middle Aged , Air Pollutants, Occupational/adverse effects , Dust , Firefighters , Lung Diseases, Obstructive/etiology , Metabolic Syndrome/blood , Occupational Exposure/adverse effects , Body Mass Index , Biomarkers/blood , Case-Control Studies , Forced Expiratory Volume , Logistic Models , Longitudinal Studies , Lung Diseases, Obstructive/blood , Lung Diseases, Obstructive/diagnosis , Metabolic Syndrome/complications , New York City , Odds Ratio , Sensitivity and Specificity , Spirometry
4.
Am J Infect Control ; 41(11): 1012-6, 2013 Nov.
Article in English | MEDLINE | ID: mdl-23972518

ABSTRACT

BACKGROUND: Hand hygiene is the most important measure to reduce health care-related infections and colonization with multiresistant micro-organisms. We sought to determine the rate and seasonality of handwashing compliance in a university-affiliated hospital. METHODS: In January 2006 (baseline period), handwashing observation was first made in an intensive care unit. From March to May 2006, there was an intervention period; and, from June 2006 to August 2009, we followed hand hygiene compliance. Seasonality curves for handwashing compliance were made during follow-up period. RESULTS: During baseline period, a total of 166 observations was made. During follow-up, 17,664 opportunities for hand hygiene were observed. Compliance improved from 30.0% to a mean of 56.7% after the intervention (P < .001). The highest mean rate of compliance was 77.9% for nurses, compared with 52.6% for technicians (P < .001) and 44.6% for physicians (P < .001). Compliance was lower during summer days (first trimester of the year) and increased after March and April and slowly decreased through the end of the year. CONCLUSION: One of the reasons for the lower handwashing compliance in the first 3 months of the year is that, in Brazil, this is the summer vacation time; and, because of that, the staff's workload and the number of less well-trained personnel are higher. We emphasize the importance of continuously monitoring hand hygiene to determine the seasonal aspects of compliance.


Subject(s)
Guideline Adherence/statistics & numerical data , Hand Hygiene/methods , Brazil , Hospitals, University , Humans , Intensive Care Units , Seasons
5.
Infect Control Hosp Epidemiol ; 32(6): 584-90, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21558771

ABSTRACT

OBJECTIVE: To evaluate the impact of ertapenem use in Pseudomonas aeruginosa carbapenem resistance, taking into account the volume of antimicrobial consumption, the consumption by the entire hospital of alcohol-based antiseptic hand rub, and the density rate of invasive practices. DESIGN: Before-and-after trial. SETTING: A tertiary care university hospital in southern Brazil. METHODS: Ertapenem was first added to the hospital formulary in June 2006, and it was excluded in February 2009. We evaluated Pseudomonas aeruginosa resistance rates through 3 study periods: period 1, before ertapenem use (17 months); period 2, during ertapenem use (33 months); and period 3, after exclusion of ertapenem (15 months). RESULTS: After introduction of ertapenem, there was a significant decrease in median consumption of imipenem or meropenem, from 2.6 to 2.2 defined daily doses (DDDs) per 100 patient-days (level change from 0.04 to -1.08; P < .01), and an increase in the use of these medications after ertapenem exclusion, from 2.2 to 3.3 DDDs per 100 patient-days (level change from -0.14 to 0.91; P < .01), by segmented regression analysis. There was no difference in the incidence density of carbapenem-resistant P. aeruginosa infection related to ertapenem use throughout the study periods. However, by multiple regression analysis, the reduction in the rate of carbapenem-resistant P. aeruginosa infection correlated significantly with the increase in the volume of alcohol used as hand sanitizer, which was from 660.7 mL per 100 patient-days in period 1 to 2,955.1 mL per 100 patient-days in period 3 (P = .04). Ertapenem use did not impact the rate of carbapenem-resistant P. aeruginosa infection. CONCLUSIONS: Use of alcohol-based hand gel, rather than ertapenem, was associated with a reduction in the rates of carbapenem-resistant P. aeruginosa infection. Measures to reduce resistance must include factors other than just antimicrobial stewardship programs alone.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Hand Disinfection/methods , Pseudomonas Infections/prevention & control , Pseudomonas aeruginosa/drug effects , beta-Lactam Resistance/drug effects , Carbapenems/therapeutic use , Cross Infection/prevention & control , Ertapenem , Hospitals, University , Humans , Incidence , Pseudomonas Infections/drug therapy , Pseudomonas Infections/epidemiology , Regression Analysis , beta-Lactams/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL